NIDA sponsors Frontiers in Addiction Research at Annual Society for Neuroscience Meeting in Orlando

October 31, 2002

The National Institute on Drug Abuse (NIDA) is sponsoring a series of satellite symposia in conjunction with the 32nd Annual Meeting of the Society for Neuroscience, to be held at the Orange County Convention Center, 9800 International Drive, Orlando, Florida. A two-day NIDA mini convention Frontiers in Addiction Research will be held November 1 and 2, a symposium Neurobiology of Relapse will be held Tuesday, November 5, and a forum Minority Scholars: Research Accomplishments and Funding Opportunities at the National Institute on Drug Abuse will be held during the Neuroscience 2002 conference.

Frontiers in Addiction Research will bring together participants from a wide array of scientific disciplines to share advances and discuss future directions in the neuroscience of drug abuse and related areas. The symposia will run from 9:00 a.m. to 9 p.m. on Friday, November 1 and from 9 a.m. to 7 p.m. on Saturday, November 2.

The schedule is as follows:

Friday, November 1Saturday, November 2As part of the agenda for Neuroscience 2002, NIDA is also sponsoring a symposium, Neurobiology of Relapse, starting at 5:30 p.m. on Tuesday, November 5 in Room 110A and B in the Orange County Convention Center. Dr. Glen Hanson, Acting NIDA Director, will lead the symposium. It will focus on the current state of knowledge about brain mechanisms underlying relapse to drug addiction, future directions for research, and implications for practice. The symposium will be followed by an opportunity to discuss these and other addiction-related issues with Dr. Hanson and other NIDA staff. In addition to Dr. Hanson, presentations will be made by Dr. Peter Kalivas, the Medical University of South Carolina; Dr. George Koob, the Scripps Research Institute; and Dr. Jane Stewart, Concordia University.

In conjunction with Neuroscience 2002, NIDA is hosting a forum, Minority Scholars: Research and Funding Opportunities at NIDA, at the Student Union on the campus of the University of Central Florida in Orlando between 5:30 and 8:30 p.m. Wednesday, November 6. The forum is designed to encourage minority scholars to pursue biomedical careers and training in drug abuse research. The forum will showcase research accomplishments of scholars at various training levels, including faculty members affiliated with minority or majority institutions. Dr. Hanson, other NIDA staff, and NIDA-supported researchers will be present to interact with forum attendees and to discuss various grant-funding opportunities at NIDA. NIDA staffers Pushpa Thadani and Don Vereen are the symposium coordinators.
-end-
For more information on any of the NIDA events, or to arrange an interview with Dr. Hanson, call Michelle Person or Blair Gately in the NIDA Press Office at 301-443-6245.

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov.

NIH/National Institute on Drug Abuse

Related Neuroscience Articles from Brightsurf:

Researchers rebuild the bridge between neuroscience and artificial intelligence
In an article in the journal Scientific Reports, researchers reveal that they have successfully rebuilt the bridge between experimental neuroscience and advanced artificial intelligence learning algorithms.

The evolution of neuroscience as a research
When the first issue of the JDR was published, the field of neuroscience did not exist but over subsequent decades neuroscience has emerged as a scientific field that has particular relevance to dentistry.

Diabetes-Alzheimer's link explored at Neuroscience 2019
Surprising links exist between diabetes and Alzheimer's disease, and researchers are beginning to unpack the pathology that connects the two.

Organoid research revealed at Neuroscience 2019
Mini-brains, also called organoids, may offer breakthroughs in clinical research by allowing scientists to study human brain cells without a human subject.

The neuroscience of autism: New clues for how condition begins
UNC School of Medicine scientists found that a gene mutation linked to autism normally works to organize the scaffolding of brain cells called radial progenitors necessary for the orderly formation of the brain.

Harnessing reliability for neuroscience research
Neuroscientists are amassing the large-scale datasets needed to study individual differences and identify biomarkers.

Blue Brain solves a century-old neuroscience problem
In a front-cover paper published in Cerebral Cortex, EPFL's Blue Brain Project, a Swiss Brain Research Initiative, explains how the shapes of neurons can be classified using mathematical methods from the field of algebraic topology.

Characterizing pig hippocampus could improve translational neuroscience
Researchers have taken further steps toward developing a superior animal model of neurological conditions such as traumatic brain injury and epilepsy, according to a study of miniature pigs published in eNeuro.

The neuroscience of human vocal pitch
Among primates, humans are uniquely able to consciously control the pitch of their voices, making it possible to hit high notes in singing or stress a word in a sentence to convey meaning.

Study tackles neuroscience claims to have disproved 'free will'
For several decades, some researchers have argued that neuroscience studies prove human actions are driven by external stimuli -- that the brain is reactive and free will is an illusion.

Read More: Neuroscience News and Neuroscience Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.